B

BioPlus Co Ltd
KOSDAQ:099430

Watchlist Manager
BioPlus Co Ltd
KOSDAQ:099430
Watchlist
Price: 7 690 KRW 1.85% Market Closed
Market Cap: 433B KRW
Have any thoughts about
BioPlus Co Ltd?
Write Note

BioPlus Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BioPlus Co Ltd
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
B
BioPlus Co Ltd
KOSDAQ:099430
Operating Income
â‚©28B
CAGR 3-Years
31%
CAGR 5-Years
48%
CAGR 10-Years
N/A
SD Biosensor Inc
KRX:137310
Operating Income
-â‚©248.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
HLB Inc
KOSDAQ:028300
Operating Income
-â‚©127.1B
CAGR 3-Years
-12%
CAGR 5-Years
-21%
CAGR 10-Years
-49%
T
T&L Co Ltd
KOSDAQ:340570
Operating Income
â‚©30.8B
CAGR 3-Years
48%
CAGR 5-Years
42%
CAGR 10-Years
N/A
H
Humasis Co Ltd
KOSDAQ:205470
Operating Income
-â‚©34B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
Interojo Co Ltd
KOSDAQ:119610
Operating Income
â‚©4.4B
CAGR 3-Years
-39%
CAGR 5-Years
-25%
CAGR 10-Years
-6%
No Stocks Found

BioPlus Co Ltd
Glance View

Market Cap
433B KRW
Industry
Health Care

BioPlus Co., Ltd. is engaged in the manufacturing and supplying of diverse dermal fillers. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2021-09-27. The firm is engaged in the production and sale of biomaterials for tissue restoration used for temporary improvement of facial wrinkles, namely hyaluronic acid fillers. In addition, the Company is engaged in the production and sale of anti-adhesion agents that reduce the formation of adhesions in surgical areas, biomaterials for joint tissue repair, and other products.

Intrinsic Value
15 791.58 KRW
Undervaluation 51%
Intrinsic Value
Price
B

See Also

What is BioPlus Co Ltd's Operating Income?
Operating Income
28B KRW

Based on the financial report for Dec 31, 2023, BioPlus Co Ltd's Operating Income amounts to 28B KRW.

What is BioPlus Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
48%

Over the last year, the Operating Income growth was 11%. The average annual Operating Income growth rates for BioPlus Co Ltd have been 31% over the past three years , 48% over the past five years .

Back to Top